Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma.

Kammerer-Jacquet SF, Deleuze A, Saout J, Mathieu R, Laguerre B, Verhoest G, Dugay F, Belaud-Rotureau MA, Bensalah K, Rioux-Leclercq N.

Int J Mol Sci. 2019 Apr 4;20(7). pii: E1692. doi: 10.3390/ijms20071692. Review.

2.

Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression.

Kammerer-Jacquet SF, Brunot A, Lefort M, Bayat S, Peyronnet B, Verhoest G, Mathieu R, Lespagnol A, Mosser J, Laguerre B, Ravaud A, Bernhard JC, Dupuis F, Yacoub M, Belaud-Rotureau MA, Bensalah K, Rioux-Leclercq N.

Clin Genitourin Cancer. 2019 Jun;17(3):169-176.e1. doi: 10.1016/j.clgc.2019.01.014. Epub 2019 Feb 4.

PMID:
30837208
3.

Whole genome duplication is an early event leading to aneuploidy in IDH-wild type glioblastoma.

Boisselier B, Dugay F, Belaud-Rotureau MA, Coutolleau A, Garcion E, Menei P, Guardiola P, Rousseau A.

Oncotarget. 2018 Nov 13;9(89):36017-36028. doi: 10.18632/oncotarget.26330. eCollection 2018 Nov 13.

4.

Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma.

Desmots F, Roussel M, Pangault C, Llamas-Gutierrez F, Pastoret C, Guiheneuf E, Le Priol J, Camara-Clayette V, Caron G, Henry C, Belaud-Rotureau MA, Godmer P, Lamy T, Jardin F, Tarte K, Ribrag V, Fest T.

Clin Cancer Res. 2019 Jan 15;25(2):735-746. doi: 10.1158/1078-0432.CCR-18-1153. Epub 2018 Oct 22.

5.

22q11.2 rearrangements found in women with low ovarian reserve and premature ovarian insufficiency.

Jaillard S, Tucker EJ, Akloul L, Beaumont M, Domin M, Pasquier L, Jouve G, Odent S, Belaud-Rotureau MA, Ravel C.

J Hum Genet. 2018 May;63(5):691-698. doi: 10.1038/s10038-018-0433-z. Epub 2018 Mar 14.

PMID:
29540854
6.

Clinicopathological characteristics of ROS1- and RET-rearranged NSCLC in caucasian patients: Data from a cohort of 713 non-squamous NSCLC lacking KRAS/EGFR/HER2/BRAF/PIK3CA/ALK alterations.

Dugay F, Llamas-Gutierrez F, Gournay M, Medane S, Mazet F, Chiforeanu DC, Becker E, Lamy R, Léna H, Rioux-Leclercq N, Belaud-Rotureau MA, Cabillic F.

Oncotarget. 2017 Jun 8;8(32):53336-53351. doi: 10.18632/oncotarget.18408. eCollection 2017 Aug 8.

7.

Comparison of human embryomorphokinetic parameters in sequential or global culture media.

Kazdar N, Brugnon F, Bouche C, Jouve G, Veau S, Drapier H, Rousseau C, Pimentel C, Viard P, Belaud-Rotureau MA, Ravel C.

Ann Biol Clin (Paris). 2017 Aug 1;75(4):403-410. doi: 10.1684/abc.2017.1259.

PMID:
28751285
8.

Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy.

Kammerer-Jacquet SF, Medane S, Bensalah K, Bernhard JC, Yacoub M, Dupuis F, Ravaud A, Verhoest G, Mathieu R, Peyronnet B, Brunot A, Laguerre B, Lespagnol A, Mosser J, Dugay F, Belaud-Rotureau MA, Rioux-Leclercq N.

Target Oncol. 2017 Aug;12(4):487-494. doi: 10.1007/s11523-017-0498-1.

PMID:
28550387
9.

Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases.

Dagher J, Kammerer-Jacquet SF, Dugay F, Beaumont M, Lespagnol A, Cornevin L, Verhoest G, Bensalah K, Rioux-Leclercq N, Belaud-Rotureau MA.

Virchows Arch. 2017 Jul;471(1):107-115. doi: 10.1007/s00428-017-2124-0. Epub 2017 May 10.

PMID:
28488172
10.

Array-CGH diagnosis in ovarian failure: identification of new molecular actors for ovarian physiology.

Jaillard S, Akloul L, Beaumont M, Hamdi-Roze H, Dubourg C, Odent S, Duros S, Dejucq-Rainsford N, Belaud-Rotureau MA, Ravel C.

J Ovarian Res. 2016 Oct 3;9(1):63.

11.

Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential.

Kammerer-Jacquet SF, Crouzet L, Brunot A, Dagher J, Pladys A, Edeline J, Laguerre B, Peyronnet B, Mathieu R, Verhoest G, Patard JJ, Lespagnol A, Mosser J, Denis M, Messai Y, Gad-Lapiteau S, Chouaib S, Belaud-Rotureau MA, Bensalah K, Rioux-Leclercq N.

Int J Cancer. 2017 Jan 1;140(1):142-148. doi: 10.1002/ijc.30429. Epub 2016 Sep 23.

12.

Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.

Kammerer-Jacquet SF, Thierry S, Cabillic F, Lannes M, Burtin F, Henno S, Dugay F, Bouzillé G, Rioux-Leclercq N, Belaud-Rotureau MA, Stock N.

Hum Pathol. 2017 Jan;59:34-40. doi: 10.1016/j.humpath.2016.08.009. Epub 2016 Sep 3.

13.

Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.

Kammerer-Jacquet SF, Brunot A, Pladys A, Bouzille G, Dagher J, Medane S, Peyronnet B, Mathieu R, Verhoest G, Bensalah K, Edeline J, Laguerre B, Lespagnol A, Mosser J, Dugay F, Belaud-Rotureau MA, Rioux-Leclercq N.

Clin Genitourin Cancer. 2017 Feb;15(1):e1-e7. doi: 10.1016/j.clgc.2016.06.007. Epub 2016 Jun 27.

14.

Wild-type VHL Clear Cell Renal Cell Carcinomas Are a Distinct Clinical and Histologic Entity: A 10-Year Follow-up.

Dagher J, Kammerer-Jacquet SF, Brunot A, Pladys A, Patard JJ, Bensalah K, Perrin C, Verhoest G, Mosser J, Lespagnol A, Vigneau C, Dugay F, Belaud-Rotureau MA, Rioux-Leclercq N.

Eur Urol Focus. 2016 Feb;1(3):284-290. doi: 10.1016/j.euf.2015.06.001. Epub 2015 Jun 17.

PMID:
28723401
15.

Karyotype is not dead (yet)!

Pasquier L, Fradin M, Chérot E, Martin-Coignard D, Colin E, Journel H, Demurger F, Akloul L, Quélin C, Jauffret V, Lucas J, Belaud-Rotureau MA, Odent S, Jaillard S.

Eur J Med Genet. 2016 Jan;59(1):11-5. doi: 10.1016/j.ejmg.2015.11.016. Epub 2015 Dec 10.

PMID:
26691665
16.

Le carcinome rénal à cellules claires (CRCC) sans altération du gène de Von Hippel-Lindau (VHL) : une entité anatomo-clinique à part ?

Brunot A, Dagher J, Perrin C, Patard JJ, Bensalah K, Verhoest G, Belaud-Rotureau M, Jouan F, Rioux-Leclercq N, Kammerer-Jacquet S.

Prog Urol. 2014 Nov;24(13):835. doi: 10.1016/j.purol.2014.08.114. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461641
17.

Clinical and molecular delineation of Tetrasomy 9p syndrome: report of 12 new cases and literature review.

El Khattabi L, Jaillard S, Andrieux J, Pasquier L, Perrin L, Capri Y, Benmansour A, Toutain A, Marcorelles P, Vincent-Delorme C, Journel H, Henry C, De Barace C, Devisme L, Dubourg C, Demurger F, Lucas J, Belaud-Rotureau MA, Amiel J, Malan V, De Blois MC, De Pontual L, Lebbar A, Le Dû N, Germain DP, Pinard JM, Pipiras E, Tabet AC, Aboura A, Verloes A.

Am J Med Genet A. 2015 Jun;167(6):1252-61. doi: 10.1002/ajmg.a.36932. Epub 2015 Apr 2. Review.

18.

Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions.

Pham-Ledard A, Cowppli-Bony A, Doussau A, Prochazkova-Carlotti M, Laharanne E, Jouary T, Belaud-Rotureau MA, Vergier B, Merlio JP, Beylot-Barry M.

Am J Clin Pathol. 2015 Mar;143(3):362-73. doi: 10.1309/AJCP4SUBR4NPSPTN.

PMID:
25696794
19.

Automation of ALK gene rearrangement testing with fluorescence in situ hybridization (FISH): a feasibility study.

Zwaenepoel K, Merkle D, Cabillic F, Berg E, Belaud-Rotureau MA, Grazioli V, Herelle O, Hummel M, Le Calve M, Lenze D, Mende S, Pauwels P, Quilichini B, Repetti E.

Exp Mol Pathol. 2015 Feb;98(1):113-8. doi: 10.1016/j.yexmp.2015.01.005. Epub 2015 Jan 8.

20.
21.

Gene dosage effects in 46, XY DSD: usefulness of CGH technologies for diagnosis.

Jaillard S, Bashamboo A, Pasquier L, Belaud-Rotureau MA, McElreavey K, Odent S, Ravel C.

J Assist Reprod Genet. 2015 Feb;32(2):287-91. doi: 10.1007/s10815-014-0383-0. Epub 2014 Nov 12. No abstract available.

22.

Sunitinib combined with angiotensin-2 type-1 receptor antagonists induces more necrosis: a murine xenograft model of renal cell carcinoma.

Verhoest G, Dolley-Hitze T, Jouan F, Belaud-Rotureau MA, Oger E, Lavenu A, Bensalah K, Arlot-Bonnemains Y, Collet N, Rioux-Leclercq N, Vigneau C.

Biomed Res Int. 2014;2014:901371. doi: 10.1155/2014/901371. Epub 2014 May 22.

23.

Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival.

Dagher J, Dugay F, Rioux-Leclercq N, Verhoest G, Oger E, Bensalah K, Cabillic F, Jouan F, Kammerer-Jacquet SF, Fergelot P, Vigneau C, Arlot-Bonnemains Y, Belaud-Rotureau MA.

Hum Pathol. 2014 Aug;45(8):1639-46. doi: 10.1016/j.humpath.2014.03.018. Epub 2014 Apr 18.

24.

Dynamic estrogen receptor interactomes control estrogen-responsive trefoil Factor (TFF) locus cell-specific activities.

Quintin J, Le Péron C, Palierne G, Bizot M, Cunha S, Sérandour AA, Avner S, Henry C, Percevault F, Belaud-Rotureau MA, Huet S, Watrin E, Eeckhoute J, Legagneux V, Salbert G, Métivier R.

Mol Cell Biol. 2014 Jul;34(13):2418-36. doi: 10.1128/MCB.00918-13. Epub 2014 Apr 21.

25.

[Cytogenetics profiles of renal carcinoma].

Dugay F, Dagher J, Verhoest G, Henry C, Jaillard S, Arlot-Bonnemains Y, Bensalah K, Vigneau C, Rioux-Leclercq N, Belaud-Rotureau MA.

Morphologie. 2014 Mar;98(320):1-7. doi: 10.1016/j.morpho.2014.02.006. Epub 2014 Mar 18. Review. French.

26.

Parallel FISH and immunohistochemical studies of ALK status in 3244 non-small-cell lung cancers reveal major discordances.

Cabillic F, Gros A, Dugay F, Begueret H, Mesturoux L, Chiforeanu DC, Dufrenot L, Jauffret V, Dachary D, Corre R, Lespagnol A, Soler G, Dagher J, Catros V, Le Calve M, Merlio JP, Belaud-Rotureau MA.

J Thorac Oncol. 2014 Mar;9(3):295-306. doi: 10.1097/JTO.0000000000000072.

27.

Postnatal diagnosis of 9q interstitial imbalances involving PTCH1, resulting from a familial intrachromosomal insertion.

Blanchard M, Dubourg C, Pasquier L, Odent S, Lucas J, Quélin C, Launay E, Akloul L, Henry C, Belaud-Rotureau MA, Dugay F, Jaillard S.

Eur J Med Genet. 2014 Apr;57(5):195-9. doi: 10.1016/j.ejmg.2013.12.010. Epub 2014 Jan 31.

PMID:
24486987
28.

[Renin-angiotensin system and urological cancers].

Verhoest G, Dolley-Hitze T, Jouan F, Bensalah K, Arlot-Bonnemains Y, Dugay F, Belaud-Rotureau MA, Rioux-Leclercq N, Vigneau C.

Prog Urol. 2014 Feb;24(2):73-9. doi: 10.1016/j.purol.2013.09.010. Epub 2013 Oct 16. Review. French.

29.

All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study.

Vigneau C, Lorcy N, Dolley-Hitze T, Jouan F, Arlot-Bonnemains Y, Laguerre B, Verhoest G, Goujon JM, Belaud-Rotureau MA, Rioux-Leclercq N.

Nephrol Dial Transplant. 2014 Feb;29(2):325-32. doi: 10.1093/ndt/gft465. Epub 2013 Dec 2.

PMID:
24302609
30.

Involvement of germline DDX1-MYCN duplication in inherited nephroblastoma.

Fievet A, Belaud-Rotureau MA, Dugay F, Abadie C, Henry C, Taque S, Andrieux J, Guyetant S, Robert M, Dubourg C, Edan C, Rioux-Leclercq N, Odent S, Jaillard S.

Eur J Med Genet. 2013 Dec;56(12):643-7. doi: 10.1016/j.ejmg.2013.10.004. Epub 2013 Oct 24.

PMID:
24161495
31.

Overexpression of the polarity protein PAR-3 in clear cell renal cell carcinoma is associated with poor prognosis.

Dugay F, Le Goff X, Rioux-Leclerq N, Chesnel F, Jouan F, Henry C, Cabillic F, Verhoest G, Vigneau C, Arlot-Bonnemains Y, Belaud-Rotureau MA.

Int J Cancer. 2014 May 1;134(9):2051-60.

32.

Histologic prognostic factors associated with chromosomal imbalances in a contemporary series of 89 clear cell renal cell carcinomas.

Dagher J, Dugay F, Verhoest G, Cabillic F, Jaillard S, Henry C, Arlot-Bonnemains Y, Bensalah K, Oger E, Vigneau C, Rioux-Leclercq N, Belaud-Rotureau MA.

Hum Pathol. 2013 Oct;44(10):2106-15. doi: 10.1016/j.humpath.2013.03.018. Epub 2013 Jun 24.

PMID:
23806527
33.

Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer.

Lavoué V, Thédrez A, Levêque J, Foucher F, Henno S, Jauffret V, Belaud-Rotureau MA, Catros V, Cabillic F.

J Transl Med. 2013 Jun 13;11:147. doi: 10.1186/1479-5876-11-147. Review.

34.

MLL-SEPT5 fusion transcript in infant acute myeloid leukemia with t(11;22)(q23;q11).

Launay E, Henry C, Meyer C, Chappé C, Taque S, Boulland ML, Ben Abdelali R, Dugay F, Marschalek R, Bastard C, Fest T, Gandemer V, Belaud-Rotureau MA.

Leuk Lymphoma. 2014 Mar;55(3):662-7. doi: 10.3109/10428194.2013.809528. Epub 2013 Aug 20. Review.

PMID:
23725386
35.

[Angiotensin-2 type 1 receptors (AT1R) and cancers].

Dolley-Hitze T, Verhoest G, Jouan F, Le Pogamp P, Arlot-Bonnemains Y, Oger E, Belaud-Rotureau MA, Rioux-Leclercq N, Vigneau C.

Nephrol Ther. 2013 Apr;9(2):85-91. doi: 10.1016/j.nephro.2012.09.006. Epub 2013 Jan 14. Review. French.

PMID:
23332110
36.

Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures.

Eimer S, Dugay F, Airiau K, Avril T, Quillien V, Belaud-Rotureau MA, Belloc F.

Neuro Oncol. 2012 Dec;14(12):1441-51. doi: 10.1093/neuonc/nos266. Epub 2012 Oct 26.

37.

[Klinefelter syndrome: spermatogenesis and quality of gametes].

Ravel C, Chantot-Bastaraud S, Cretet J, Roynard P, Sibony M, Maurin N, Belaud-Rotureau MA, Berthaut I.

Gynecol Obstet Fertil. 2011 Sep;39(9):525-8. doi: 10.1016/j.gyobfe.2011.07.003. Epub 2011 Aug 10. French.

PMID:
21835669
38.

5q12.1 deletion: delineation of a phenotype including mental retardation and ocular defects.

Jaillard S, Andrieux J, Plessis G, Krepischi AC, Lucas J, David V, Le Brun M, Bertola DR, David A, Belaud-Rotureau MA, Mosser J, Lazaro L, Treguier C, Rosenberg C, Odent S, Dubourg C.

Am J Med Genet A. 2011 Apr;155A(4):725-31. doi: 10.1002/ajmg.a.33758. Epub 2011 Mar 15.

PMID:
21594994
39.

Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death.

Eimer S, Belaud-Rotureau MA, Airiau K, Jeanneteau M, Laharanne E, Véron N, Vital A, Loiseau H, Merlio JP, Belloc F.

Cancer Biol Ther. 2011 Jun 15;11(12):1017-27. Epub 2011 Jun 15.

PMID:
21508666
40.

Terminal 6.9 Mb deletion of chromosome 15q, associated with a structurally abnormal X chromosome in a patient with congenital diaphragmatic hernia and heart defect.

Jaillard S, Loget P, Lucas J, Dubourg C, Le Bouar G, Demurger F, Bertorello I, David V, Poulain P, Odent S, Belaud-Rotureau MA.

Eur J Med Genet. 2011 Mar-Apr;54(2):186-8. doi: 10.1016/j.ejmg.2010.11.001. Epub 2010 Nov 27.

PMID:
21115145
41.

Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?

Dolley-Hitze T, Jouan F, Martin B, Mottier S, Edeline J, Moranne O, Le Pogamp P, Belaud-Rotureau MA, Patard JJ, Rioux-Leclercq N, Vigneau C.

Br J Cancer. 2010 Nov 23;103(11):1698-705. doi: 10.1038/sj.bjc.6605866.

42.

Synthesis of N-aryl and N-alkyl anthranilic acids via S(N)Ar reaction of unprotected 2-fluoro- and 2-methoxybenzoic acids by lithioamides.

Belaud-Rotureau M, Le TT, Phan TH, Nguyen TH, Aissaoui R, Gohier F, Derdour A, Nourry A, Castanet AS, Nguyen KP, Mortier J.

Org Lett. 2010 May 21;12(10):2406-9. doi: 10.1021/ol1007586.

PMID:
20429533
43.

[Composite lymphoma: association of a follicular lymphoma and a chronic lymphocytic leukemia].

Rabiller F, Belaud-Rotureau MA, Fitoussi O, Dubus P, Merlio JP, de Mascarel A, Parrens M.

Ann Pathol. 2008 Feb;28(1):41-4. doi: 10.1016/j.annpat.2007.09.001. Epub 2008 May 16. French.

PMID:
18538714
44.

Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas.

Belaud-Rotureau MA, Marietta V, Vergier B, Mainhaguiet G, Turmo M, Idrissi Y, Ferrer J, Beylot-Barry M, Dubus P, Merlio JP.

Virchows Arch. 2008 Jun;452(6):607-20. doi: 10.1007/s00428-008-0593-x. Epub 2008 Mar 1.

PMID:
18311490
45.

Common chromosomal abnormalities in mycosis fungoides transformation.

Prochazkova M, Chevret E, Mainhaguiet G, Sobotka J, Vergier B, Belaud-Rotureau MA, Beylot-Barry M, Merlio JP.

Genes Chromosomes Cancer. 2007 Sep;46(9):828-38.

PMID:
17584911
46.

[Optimized protocols for interphase FISH analysis of imprints and sections using split signal probes].

Pelluard-Nehme F, Dupont T, Turmo M, Merlio JP, Belaud-Rotureau MA.

Morphologie. 2007 Mar;91(292):52-60. French.

PMID:
17574471
47.

EBV-positive lymphoproliferative disease with medullary, splenic and hepatic infiltration after imatinib mesylate therapy for chronic myeloid leukemia.

Leguay T, Foucaud C, Parrens M, Fitoussi O, Bouabdallah K, Belaud-Rotureau MA, Tabrizi R, Marit G, Pigneux A, Milpied N.

Leukemia. 2007 Oct;21(10):2208-10. Epub 2007 May 31. No abstract available.

PMID:
17541400
48.

FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients.

Hagedorn M, Delugin M, Abraldes I, Allain N, Belaud-Rotureau MA, Turmo M, Prigent C, Loiseau H, Bikfalvi A, Javerzat S.

Cell Div. 2007 Feb 27;2:9.

49.

Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.

Belaud-Rotureau MA, Parrens M, Carrere N, Turmo M, Ferrer J, de Mascarel A, Dubus P, Merlio JP.

Hum Pathol. 2007 Feb;38(2):365-72. Epub 2006 Nov 28.

PMID:
17134735
50.

Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.

Parrens M, Belaud-Rotureau MA, Fitoussi O, Carerre N, Bouabdallah K, Marit G, Dubus P, de Mascarel A, Merlio JP.

Histopathology. 2006 Mar;48(4):353-62.

PMID:
16487357

Supplemental Content

Loading ...
Support Center